Nursing homes wont be required tohire independent pharmacists to assess residents prescriptions,as U.S. regulators backtrack on a offer from six months agothat sent Omnicare Inc. (OCR) and PharMerica Corp. (PMC) shares tumbling. The Centers for Medicare and Medicaid Services in Octobersaid it was considering stricter rules to manage patients drugregimens. In a regulatory filing today, a agency pronounced itdecided against a process because it would be highlydisruptive to a industry without reducing drug utilization. The agency decided to further investigate a issue for futurepolicy considerations, pronounced Jonathan Blum, deputy director ofthe centers, in a conference call with reporters. Nursing home staff and physicians contributesignificantly to a problem along with pharmacists, theagency said. While a agency is leaving process a same fornow, it pronounced changes are necessary and a requirement forconsultant pharmacist independence is part of a rightapproach. Omnicare, a largest nursing home pharmacy by sales,dropped a $441 million bid to acquire PharMerica in Februaryafter a Federal Trade Commission sued to block a deal. Thecombined companies would have controlled as much as 60 percentof a market to distribute drug to nursing homes, hospitalsand hospices, according to Jeff Jonas, an analyst during Gabelli &Co. in Rye, New York. To contact a reporter on this story:Alex Wayne in Washington during awayne3@bloomberg.net To contact a editor responsible for this story:Reg Gale during rgale5@bloomberg.net LinkedIn Google +1 COMMENTS Print Please enable JavaScript to perspective a comments powered by Disqus. Powered By iWebRSS.co.cc
Nursing Careers
No comments:
Post a Comment